Efficient detection and post-surgical monitoring of colon cancer with a multi-marker DNA methylation liquid biopsy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficient detection and post-surgical monitoring of colon cancer with a multi-marker DNA methylation liquid biopsy
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 118, Issue 5, Pages e2017421118
Publisher
Proceedings of the National Academy of Sciences
Online
2021-01-26
DOI
10.1073/pnas.2017421118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
- (2020) Huiyan Luo et al. Science Translational Medicine
- DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
- (2020) Vera Constâncio et al. Cells
- Integrating genomic features for non-invasive early lung cancer detection
- (2020) Jacob J. Chabon et al. NATURE
- Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
- (2020) Asaf Zviran et al. NATURE MEDICINE
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
- (2020) M.C. Liu et al. ANNALS OF ONCOLOGY
- Non-invasive early detection of cancer four years before conventional diagnosis using a blood test
- (2020) Xingdong Chen et al. Nature Communications
- Clinical utility of circulating tumor DNA for colorectal cancer
- (2019) Hiroki Osumi et al. CANCER SCIENCE
- Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
- (2019) Thomas Reinert et al. JAMA Oncology
- Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
- (2019) N Tarazona et al. ANNALS OF ONCOLOGY
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
- (2019) Pedram Razavi et al. NATURE MEDICINE
- Dynamics of Plasma EGFR T790M Mutation in Advanced NSCLC: A Multicenter Study
- (2019) Zhengquan Yang et al. Targeted Oncology
- Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
- (2018) Jeanne Tie et al. GUT
- Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer
- (2018) Rebecca A. Snyder et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial
- (2018) Zhijie Wang et al. Lancet Respiratory Medicine
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sensitive tumour detection and classification using plasma cell-free DNA methylomes
- (2018) Shu Yi Shen et al. NATURE
- Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA
- (2017) Shicheng Guo et al. NATURE GENETICS
- Integrating liquid biopsies into the management of cancer
- (2017) Giulia Siravegna et al. Nature Reviews Clinical Oncology
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
- (2016) Jeanne Tie et al. Science Translational Medicine
- Population-Based Colonoscopy Screening for Colorectal Cancer
- (2016) Michael Bretthauer et al. JAMA Internal Medicine
- Postoperative serum methylation levels ofTAC1andSEPT9are independent predictors of recurrence and survival of patients with colorectal cancer
- (2014) CheeKian Tham et al. CANCER
- Prospective evaluation of methylatedSEPT9in plasma for detection of asymptomatic colorectal cancer
- (2013) Timothy Robert Church et al. GUT
- Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement
- (2013) Jeffrey A. Meyerhardt et al. JOURNAL OF CLINICAL ONCOLOGY
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
- (2012) H. J. Schmoll et al. ANNALS OF ONCOLOGY
- Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
- (2011) Jorja D Warren et al. BMC Medicine
- Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
- (2009) T. deVos et al. CLINICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started